| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 28 |
| 1 | ASPIRIN | 16 |
| 2 | ASPIRIN 325 MG | 16 |
| 3 | ASPIRIN 81 MG | 16 |
| 4 | OMEPRAZOLE | 16 |
| 5 | OMEPRAZOLE MAGNESIUM | 16 |
| 6 | ERGOCALCIFEROL | 13 |
| 7 | FUROSEMIDE | 13 |
| 8 | LISINOPRIL | 12 |
| 9 | ACETAMINOPHEN | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0263 |
| 1 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS | 1 | 0.0026 |
| 2 | AZELASTINE HCL | 2 | 0.0014 |
| 3 | SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE | 1 | 0.0010 |
| 4 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| 5 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 6 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 7 | TREMELIMUMAB | 3 | 0.0007 |
| 8 | TIVOZANIB | 1 | 0.0006 |
| 9 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 34 |
| 1 | Proton Pump Inhibitor [EPC] | 28 |
| 2 | Corticosteroid [EPC] | 24 |
| 3 | Benzodiazepine [EPC] | 19 |
| 4 | Kinase Inhibitor [EPC] | 17 |
| 5 | Osmotic Laxative [EPC] | 17 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 17 |
| 7 | GLP-1 Receptor Agonist [EPC] | 15 |
| 8 | Insulin Analog [EPC] | 14 |
| 9 | Vitamin C [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 1 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 4 | Prostaglandin E1 Analog [EPC] | 3 | 0.0002 |
| 5 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Non-Standardized Plant Allergenic Extract [EPC] | 2 | 0.0001 |
| 8 | Muscle Relaxant [EPC] | 5 | 0.0001 |
| 9 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 6 | 0.0001 |